Over the past decade, many studies have shown a causal role of protein kinase dysregulations or mutations in different human disorders, including Alzheimer’s and Parkinson’s disease, diabetes, atherosclerosis, stroke, and inflammatory diseases (rheumatoid arthritis, Crohn’s disease) [4], which made them particularly sensitive to appropriate protein kinase inhibitors. Here, WEE1 is linked to stroke disorder.